What's breaking now, across thousands of outlets.
(MedPage Today) -- ORLANDO -- A large head-to-head trial reported here that pitted bimekizumab (Bimzelx) against risankizumab (Skyrizi) as treatment for psoriatic arthritis (PsA) yielded a winner, albeit with a couple caveats. Arthritic symptoms...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
From the Handelsblatt archive: Investors and pharmaceutical companies are investing billions in products for women in menopause. Nevertheless, there is a lack of effective therapies.
A new study found that energy drinks and stimulant supplements were linked to disproportionately frequent reports of serious heart problems, including 11 times more reports of cardiac arrest and 4.5…
A new study found that energy drinks and stimulant supplements were linked to disproportionately frequent reports of serious heart problems, including 11 times more reports of cardiac arrest and 4.5…
KOTA KINABALU: Sabah has successfully performed its second separation surgery on conjoined twins, bringing forward the operation after one of the babies required increasing respiratory support.
New research led by QIMR Berghofer has uncovered a decades-long increase in the rates of a common form of skin cancer across Australia and Europe, highlighting a growing but underrecognized public…
The deal gives AstraZeneca a simpler way to make conjugate vaccines. Elsewhere, a psychedelic depression drug was submitted to the FDA and an autoimmune disease-focused biotech’s shares collapsed.
